BGMSP Projected Dividend Yield

Pfd Conv Exchangeable 6%/Bio Green Med Solution Inc ( OTCBB : BGMSP )

Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is evaluating fadraciclib, a Cyclin-dependent kinase 9 (CDK9) inhibitor, in solid tumors and hematological malignancies. The epigenetic/anti-mitotic program is evaluating plogosertib, in solid tumors and hematological malignancies.

11 YEAR PERFORMANCE RESULTS

BGMSP Dividend History Detail
BGMSP Dividend News
BGMSP Competitors News

# of Shares: 0

Closing Price: 3.50

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2025	0.15	0%	0	$ 0.00	0.00%
2026	0.60	0%	0	$ 0.00	17.14%
2027	0.45	0%	0	$ 0.00	17.14%
2028	0.45	0%	0	$ 0.00	17.14%
2029	0.45	0%	0	$ 0.00	17.14%
2030	0.45	0%	0	$ 0.00	17.14%
2031	0.45	0%	0	$ 0.00	17.14%
2032	0.45	0%	0	$ 0.00	17.14%
2033	0.45	0%	0	$ 0.00	17.14%
2034	0.45	0%	0	$ 0.00	17.14%
2035	0.45	0%	0	$ 0.00	17.14%
2036	0.45	0%	0	$ 0.00	17.14%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10yrs would be $ 0.00 with a yield on cost % of 17.14%
Rolling Last 4 qtrs dividends total $ 0.45 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.45 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
2026	May 14, 2026	Apr 23, 2026	Apr 23, 2026	May 01, 2026	0.1500
2026	Jan 12, 2026	Jan 22, 2026	Jan 22, 2026	Feb 01, 2026	0.1500
2026 Total:					0.3000
2025	Oct 07, 2025	Oct 20, 2025	Oct 20, 2025	Nov 01, 2025	0.1500
2025 Total:					0.1500